Since ERK1/ERK2 signaling pathway is critical in the tumor angiogenesis 30, 31, we inferred that ERβ might involve in the angiogenesis via ERK1/ERK2 signaling pathway, which might serve as a non-hormonal therapy target. This evidence concerns the gene MAPK3 and neoplasm.